- Home
- LLYVA vs TECH Comparison
LLYVA vs TECH Comparison
Compare LLYVA & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LLYVA
- TECH
- Stock Information
- Founded
- LLYVA 1991
- TECH 1976
- Country
- LLYVA United States
- TECH United States
- Employees
- LLYVA N/A
- TECH N/A
- Industry
- LLYVA Broadcasting
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LLYVA Industrials
- TECH Health Care
- Exchange
- LLYVA Nasdaq
- TECH Nasdaq
- Market Cap
- LLYVA 7.1B
- TECH 7.8B
- IPO Year
- LLYVA N/A
- TECH 1989
- Fundamental
- Price
- LLYVA $78.44
- TECH $49.89
- Analyst Decision
- LLYVA
- TECH Buy
- Analyst Count
- LLYVA 0
- TECH 11
- Target Price
- LLYVA N/A
- TECH $72.00
- AVG Volume (30 Days)
- LLYVA 89.0K
- TECH 2.5M
- Earning Date
- LLYVA 01-01-0001
- TECH 08-06-2025
- Dividend Yield
- LLYVA N/A
- TECH 0.64%
- EPS Growth
- LLYVA N/A
- TECH N/A
- EPS
- LLYVA 0.27
- TECH 0.83
- Revenue
- LLYVA N/A
- TECH $1,208,770,000.00
- Revenue This Year
- LLYVA $7.29
- TECH $7.07
- Revenue Next Year
- LLYVA N/A
- TECH $5.88
- P/E Ratio
- LLYVA $289.58
- TECH $60.23
- Revenue Growth
- LLYVA N/A
- TECH 4.72
- 52 Week Low
- LLYVA $34.56
- TECH $46.01
- 52 Week High
- LLYVA $79.78
- TECH $83.62
- Technical
- Relative Strength Index (RSI)
- LLYVA 63.75
- TECH 49.63
- Support Level
- LLYVA $72.09
- TECH $49.05
- Resistance Level
- LLYVA $75.73
- TECH $51.66
- Average True Range (ATR)
- LLYVA 1.83
- TECH 1.59
- MACD
- LLYVA 0.27
- TECH 0.17
- Stochastic Oscillator
- LLYVA 84.63
- TECH 47.40
About LLYVA Liberty Media Corporation Series A Liberty Live
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.